Related Experiment Video

Updated: May 2, 2026

Tilt Testing with Combined Lower Body Negative Pressure: a "Gold Standard" for Measuring Orthostatic Tolerance
14:09

Tilt Testing with Combined Lower Body Negative Pressure: a "Gold Standard" for Measuring Orthostatic Tolerance

Published on: March 21, 2013

20.7K

Orthostatic hypotension and cognitive impairment: a dangerous association?

Luisa Sambati1, Giovanna Calandra-Buonaura, Roberto Poda

  • 1IRCCS Istituto delle Scienze Neurologiche di Bologna e Dipartimento di Scienze Biomediche e NeuroMotorie, Alma Mater Studiorum, Università di Bologna, Bologna, Italy, luisa.sambati2@unibo.it.

Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|March 5, 2014
PubMed

Insights

Orthostatic hypotension (OH) and cognitive impairment (CI) often coexist in the elderly, but their causal link remains unclear. Further longitudinal studies are needed to understand if OH causes CI or if they share common causes.

Area of Science:

  • Gerontology
  • Neurology
  • Cardiology

Background:

  • Orthostatic hypotension (OH) and cognitive impairment (CI) are prevalent in the elderly.
  • The relationship between OH and CI, including in conditions like Parkinson's disease, is complex and debated.
  • Existing research presents conflicting findings on their coexistence and causal link.

Purpose of the Study:

  • To review existing literature on the relationship between orthostatic hypotension and cognitive impairment.
  • To explore hypotheses regarding the potential causal pathways between OH and CI.
  • To highlight the need for further research, particularly longitudinal studies.

Main Methods:

  • Literature review of studies investigating OH and CI.
  • Analysis of proposed hypotheses on the OH-CI relationship.
  • Synthesis of findings from studies in elderly populations, mild cognitive impairment, dementias, and movement disorders.

Main Results:

  • Three main hypotheses regarding the OH-CI relationship were identified: common pathological process, OH-induced cerebral hypoperfusion, and CI as a transient OH symptom.
  • Evidence for a definitive causal relationship or shared etiology is controversial.
  • The review underscores inconsistencies in current research findings.

Conclusions:

  • The precise relationship between orthostatic hypotension and cognitive impairment requires further elucidation.
  • Longitudinal studies are crucial to determine causality and the temporal relationship between OH and CI.
  • Understanding this link is vital for managing cognitive health in aging populations.

More Related Videos

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients07:42

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients

Published on: December 16, 2022

3.1K
Computerized Dynamic Posturography for Postural Control Assessment in Patients with Intermittent Claudication14:52

Computerized Dynamic Posturography for Postural Control Assessment in Patients with Intermittent Claudication

Published on: December 11, 2013

11.3K

Related Concept Videos

Alterations in Blood Pressure01:30

Alterations in Blood Pressure

Alterations in blood pressure, such as hypertension (high blood pressure) and hypotension (low blood pressure), significantly affect human health. Understanding these conditions' classifications, causes, and symptoms is essential for effective management and treatment.
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...
2.1K
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
395
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
926
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
379
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic...
53
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
886